Literature DB >> 29560666

Persistent Systemic Inflammatory Response Syndrome predicts the need for tertiary care in Acute Pancreatitis.

Biku Joseph John1, Swaminathan Sambandam1, Prerna Garg2, Gursharan Singh1, Maninder Kaur1, Rathi Baskaran1, Gautham Srinivasan1, Venkatakrishnan Leelakrishnan3, Krishnaveni Janarthan3.   

Abstract

INTRODUCTION: Patients with Acute Pancreatitis (AP) presenting with Systemic Inflammatory Response syndrome (SIRS) are more likely to have severe acute pancreatitis and are at increased risk of complications. Additionally, persistence of SIRS at 48 hrs after admission is associated with persistent organ failure and a worse outcome. We investigated the usefulness of SIRS as a criterion for referring patients to a tertiary pancreatic care centre.
MATERIAL AND METHODS: Retrospective analyses of patients admitted with AP over a one year period. Patients were classified into 2 severity groups - 1) Mild AP, 2) Moderate and Severe AP (MASP) as per the Revised Atlanta Classification. SIRS was determined at presentation and following 48 hours of best medical management. Outcomes were compared between patients who had no SIRS at presentation, transient SIRS(SIRS≤48hrs) and persistent SIRS(>48hrs).
RESULTS: 134 patients were included in the study. SIRS at presentation had a sensitivity of 88%(95% CI 75-96) and a specificity of 66%(95% CI 55-75) in predicting MASP. However, persistent SIRS and recovery from SIRS within 48hrs were poor predictors of MASP. Only 23/43 (53.5%) patients with MASP had persistent SIRS. Interestingly, MASP patients with persistant SIRS had a significant higher risk of complications, readmission, intervention, culture positivity and hospital stay as compared to those with transient SIRS.
CONCLUSION: Persistent SIRS could be used to identify patients with MASP requiring tertiary care. This could be used as an effective tool by community hospitals with limited facilities. Further, prospective studies are required to validate our findings. © Acta Gastro-Enterologica Belgica.

Entities:  

Keywords:  SIRS; pancreatitis; referral

Mesh:

Year:  2017        PMID: 29560666

Source DB:  PubMed          Journal:  Acta Gastroenterol Belg        ISSN: 1784-3227            Impact factor:   1.316


  3 in total

1.  Clinical Outcomes of Acute Pancreatitis in Patients with Cirrhosis According to Liver Disease Severity Scores.

Authors:  C Roberto Simons-Linares; Suha Abushamma; Carlos Romero-Marrero; Amit Bhatt; Rocio Lopez; Sunguk Jang; John Vargo; Tyler Stevens; Robert O'Shea; William Carey; Prabhleen Chahal
Journal:  Dig Dis Sci       Date:  2020-09-06       Impact factor: 3.199

2.  Acute Pancreatitis in Patients with a History of Bariatric Surgery: Is It Less Severe?

Authors:  Paul Thomas Kröner; C Roberto Simons-Linares; Alex M Kesler; Peter Abader; Mohammad Afsh; Juan Corral; John Rodriguez; John J Vargo; Massimo Raimondo; Prabhleen Chahal
Journal:  Obes Surg       Date:  2020-06       Impact factor: 4.129

3.  Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trial.

Authors:  Cecilie Siggaard Knoph; Mathias Ellgaard Cook; Camilla Ann Fjelsted; Srdan Novovic; Michael Bau Mortensen; Liv Bjerre Juul Nielsen; Mark Berner Hansen; Jens Brøndum Frøkjær; Søren Schou Olesen; Asbjørn Mohr Drewes
Journal:  Trials       Date:  2021-12-19       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.